We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Science In Sport Plc | LSE:SIS | London | Ordinary Share | GB00BBPV5329 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 15.75 | 15.50 | 16.00 | 15.75 | 15.75 | 15.75 | 111,056 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Health & Allied Services,nec | 63.77M | -10.91M | -0.0640 | -2.46 | 26.83M |
Date | Subject | Author | Discuss |
---|---|---|---|
21/2/2024 12:50 | Decent buying volume last couple of days | hezza123 | |
04/2/2024 22:39 | It certainly does & other than L.O. buying recently, no one else seems to have noticed. | arb1trager | |
03/2/2024 11:18 | Sector about to get very interesting Mark Kleinman@MarkKleinma | arb1trager | |
05/1/2024 20:04 | As an outsider looking in, it looks like (probably) ex-CEO exercised an option on 9.8 million shares, and immediately sold them, 9.7 million being bought by LO. Otherwise most likely would've sold them into the market and caused the price to drop. | bozzy_s | |
05/1/2024 13:42 | Seems something big is going on in the background, a possible squeeze out...Squeeze-out is the forced sale of stock owned by minority shareholders in a joint-stock company, usually in the context of an acquisition. State law governs squeeze-outs and requires fair cash value be paid to the minority shareholders from the acquiring corporation in exchange for their stock. | benny shares | |
05/1/2024 11:29 | Some decent buying by Lombard and management | mirabeau | |
03/1/2024 21:34 | Huge volume last 2 days | aughton 3 | |
19/10/2023 07:49 | Moon gone. RNS out. | lammylover | |
28/9/2023 08:57 | I tried to read the headline figures and am off to specsavers. | mr macgregor | |
28/9/2023 07:17 | Still loss making. Massive avoid. | terminator101 | |
28/7/2023 14:25 | CEO didn't even turn up to the agm ! | aughton 3 | |
04/7/2023 07:26 | £10 million loss. Gulp. But at least you can be assured that no Director suffered as a result and that KM’s £554,000 renumeration is secure. Phew. | terminator101 | |
03/7/2023 08:15 | Oh dear, oh dear. | rich1952 | |
29/6/2023 09:41 | Still yet to see the evidence that current management can actually run this business profitably | nchanning | |
07/4/2023 08:19 | Wow 85p to 7p in less than 2 years. Wonder if they will make a comment on the 37% drop on Tuesday? Not looking good, but the involvement of Lombard odier in the last placing at 15p is always a big red flag. | terminator101 | |
23/2/2023 13:29 | So whats left to go wrong here? (in the near/short term?) | se81 | |
05/10/2022 14:03 | Moon reminds me of Finchy from the Office . The guy is delusional about the years of losses , this is not an enterprise software business where customers have a high lifetime value / acquisition cost . It's a simple consumer business that needs to be run profitably to be worth anything at all . Can it be run with say a 7% operating margin by new management with established brands ? Maybe , but no point investing here until Moon is gone | nchanning | |
30/9/2022 17:42 | Its just not a business that can be made profitable. The constant marketing required just to maintain sales is a drag. Whatever they say about brand loyalty is rubbish - the market is awash with brands. Best bet for any fancy new "science" based sports nutrition business is to build up a brand quickly and then either float or get bought out, by someone who thinks they can beat the headwind and make a profit. | yump | |
30/9/2022 12:49 | Moon is simply unfit to hold the position of director in any publicly quoted entity. | redprince | |
30/9/2022 11:19 | Moon will take this down like he did PXS, he is a pillock | horridhenry | |
30/9/2022 11:16 | All fluff and no substance | scepticalinvestor |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions